Although the methods and experimental conditions are different, the trends are similar: MIA PaCa-2, which is a human pancreatic cell line with mutant KRAS, demonstrated obviously elevated macropinocytosis compared to the KRAS wt pancreatic cancer cell line BxPC-3. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.